Zambart

24/07/2025

We're thrilled to announce that our staff members Dr. Mwelwa Phiri and Sophie Inambwae of the STI Prevalence Study in Zambia (Chongetsa) will be attending the STI & HIV 2025 World Congress in Montreal, Canada! The congress, themed "Sexual Health for All," will take place from July 26-30, 2025, at the Palais des Congrès de Montréal.
Dr. Phiri's oral presentation will focus on the Prevalence of Four Sexually Transmitted Infections Among Adolescents and Young People Aged 15 to 24 in Lusaka, Zambia.
The conference is organized by the International Society for Sexually Transmitted Diseases Research (ISSTDR) and the International Union against Sexually Transmitted Infections (IUSTI) brings together global experts to share groundbreaking research and best practices in STI and HIV prevention and treatment.
Gates FoundationMinistry of Health ZambiaLondon School of Hygiene & Tropical MedicineNational HIV/AIDS/STI/TB Council ZambiaInstituut voor Tropische Geneeskunde | Institute of Tropical Medicine

23/07/2025

Zambart Launches Community-Based Ear and Hearing Care Project
https://www.zambart.org.zm/2025/07/23/zambart-launches-community-based-ear-and-hearing-care-project/

21/07/2025

We Are Employing!!

Zambart is an independent Zambian research organization whose headquarters is at the University of Zambia’s Ridgeway Campus in Lusaka. Zambart is globally renowned for its interdisciplinary research on HIV and Tuberculosis and has contributed to HIV and TB policy and practice at national and global levels. Zambart’s research portfolio now includes a broader scope of urgent public health issues. Zambart staff form an interdisciplinary team with a range of expertise including epidemiology, clinical science, social science, laboratory, operations research, health systems and services research, health policy analysis, health economics, health communication and counselling.

Zambart’ s vision is to conduct quality interdisciplinary health research on issues of public health importance Zambia and contribute to improving health policy and practice leading to better health for all.

Our mission is to contribute to global public health policy and practice through the generation of an evidence based by conducting high-quality health research in Zambia.
To support our wide range of research activities, we are looking for an ambitious, suitably qualified candidate to fill the following exciting position that has arisen:

Position: Clinical Officers (02)
Reporting To: Study Manager
Job Location: Lusaka – Kanyama First Level Hospital

Job Summary
Zambart is conducting a randomised diagnostic accuracy study evaluating lung ultrasound (LUS) as a point-of-care tool for the diagnosis of pulmonary tuberculosis (PTB). The study will assess the diagnostic performance of different ultrasound protocols and probe types and is being implemented at Kanyama First Level Hospital in Lusaka.

We are seeking experienced Clinical Officers to support the implementation of this study, including participant recruitment, clinical assessments, and collaboration with the hospital team.
Key Responsibilities include and not limited to:
1. Clinical and Research Duties:
• Conduct informed consent discussions and obtain written consent from study participants.
• Perform clinical evaluations of participants including history taking, physical examination, and symptom screening.
• Accurately document clinical and sonographic findings in study of CRFs and electronic data systems.
• Assist in sputum sample collection, TB testing procedures, and follow-up referrals, where necessary
• Monitor for and report adverse events according to study procedures.
• Work collaboratively with hospital staff to ensure smooth integration of study procedures within clinical care.
• Participate in quality assurance activities
2. Operational and Administrative Support:
• Maintain participant logs and ensure accurate and timely data entry.
• Report daily study progress and any challenges encountered to the study manager
• Participate in regular study team meetings, refresher training, and site monitoring visits.
• Ensure confidentiality and ethical handling of participant data and biological samples.

Qualifications and Experience
Essential Requirements:
• Diploma or Degree in Clinical Medical Sciences (Clinical Officer General or equivalent)
• Registered with the Health Professions Council of Zambia (HPCZ)
• Minimum 2 years of post-qualification clinical experience
• Prior experience in TB diagnosis and management
• Strong interpersonal and communication skills
• Fluency in English and Nyanja or Bemba
• Basic computer literacy (data entry, MS Word, Excel)
Desirable:
• Experience in research or clinical trials
• Prior training or experience in point-of-care ultrasound
• GCP (Good Clinical Practice) certification

How to Apply
Applicants meeting the criteria for the above jobs should send their latest CVs, HPCZ registration Certificate, three traceable references contacts, and a cover letter outlining clearly how they meet the above criteria to: The Head of Human Resources, Zambart Head Office, Ridgeway Campus, P.O Box 50697, Lusaka or send your application via email to jobs@zambart.org.zm

Closing Date:
The closing date for the receipt of the applications will be 24th July 2025.
Only short-listed candidates will be contacted.

18/07/2025

Communities at the Centre: Powering HIV and TB Research through Meaningful Community Engagement -Lessons Learned from Zambia webinar.
This IAS 2025 Affiliated Independent event is now live! Kindly register to join and learn from our Community Engagement team.

https://lnkd.in/eEWEEzMx
hashtag

16/07/2025

Communities at the Centre: Powering HIV and TB Research through Meaningful Community Engagement -Lessons Learned from Zambia is an hashtag Affiliated Independent Event.

Join us at the world’s most influential meeting on HIV research and its applications in Kigali, Rwanda, from 13 to 17 July 2025 https://lnkd.in/dnjNWJez
Follow the link below to register for webinar on Friday 18th July, 2025 from 09:00 - 10:30 hrs
https://lnkd.in/dzBMzUdU
International AIDS Society

07/07/2025

Happy Heroes Day from Zambart!

03/07/2025

Zambart has introduced a new study, *ZAMSA-TB*, aimed at improving epidemiological methods for surveillance of Mycobacterium tuberculosis (Mtb) infection.
The Zambia- Malawi - South Africa (ZAMSA) Study, will be conducted in Chipata and Kanyama First Level Hospitals and their catchment communities, and seeks to validate a convenience sampling surveillance methodology using young children as a sentinel population indicative of recent community transmissions. The study will also identify high-risk groups and areas for targeted interventions and utilize data to simulate evaluations of novel TB prevention interventions. The ZAMSA study will be referred to as ‘ Atontho’, meaning ‘young children’ in Chinyanja, will also be conducted in Cape Town, South Africa and Blantyre, Malawi.
The study will recruit approximately 2,400 children from both communities over approximately 18 months. In the health facilities, children aged 1-5 visiting for non-illness-related reasons will be sampled conveniently and tested for Mtb infection using interferon gamma release assay (IGRA), and their households will be geolocated using the Electronic Participant Locator (ePaL). In the catchment communities of both facilities, parallel random household sampling will identify similar aged children for IGRA testing to validate the proposed convenience sampling technique.
The ZAMSA-TB Study also aims to contribute significantly to the understanding of recent TB transmissions in communities, ultimately informing the deployment of prevention strategies and the efficient evaluation of population-wide interventions.
By advancing epidemiological methods for surveillance, this study has the potential to enhance TB control efforts in Zambia and beyond. Zambart's commitment to conducting high-quality research underscores its dedication to improving health outcomes in the region. Ministry of Health Zambia University of Glasgow Malawi Liverpool Wellcome Programme University of Cape Town CIDRI-Africa

01/07/2025

Exciting news! Zambart launched Mugwilizano, a new project to combat malnutrition among TB patients. The project will be conducted in Kanyama, Lusaka and is generously being funded by the French Embassy. Thank you, H.E. Mr. Thomas Rossignol, Ambassador of France to Zambia, for your support! Ministry of Health Zambia France_en_Zambie

01/07/2025

25/06/2025

Raising Awareness about HPV

In the picture, one of our Senior Research Assistants Mwanza, working on the Global Burden Estimation of Human Papillomavirus (GLOBE-HPV) Study, is demonstrating a virginal swab collection for HPV testing.

The GLOBE-HPV study in Zambia is part of a larger multi-national project funded by the Gates Foundation (GF) and implemented by Zambart in collaboration with the of Health. The study aims to estimate the prevalence (single time point detection) of HPV 16 and/or 18 infection among a representative sample of girls and women aged 9-50y in a range of settings and the incidence of 6-month persistent HPV 16 and/or 18 infection in selected populations over 2 years.

This study is being conducted in 7 other countries: 5 in Africa and 3 in South Asia.

Key facts about HPV
• According to WHO, persistent HPV infection with high-risk HPV types is the cause of cervical cancer.
• Zambia has the third highest burden of cervical cancer in the world.
• Cervical cancer ranks as the 1st most frequent cancer among women in Zambia and the 1st most frequent cancer among women between 15 and 44 years of age.
• HPV-screening and prophylactic vaccination against HPV can prevent cervical cancer.

Screening and testing are essential in detecting and treating these infections early.

Ministry of Health Zambia London School of Hygiene & Tropical Medicine National HIV/AIDS/STI/TB Council Zambia International Vaccine Institute Karolinska Institutet Gates Foundation

23/06/2025

Partnerships Pay Off: Zambart's Success Story

Zambart, recently won the esteemed EDCTP Outstanding Research Team Prize at the Global Health Forum in Kigali, Rwanda. The award recognizes Zambart's outstanding contributions to global public health research.

In her acceptance speech, Zambart Executive Director, Dr. Kwame Shanaube expressed heartfelt gratitude to the Global Health EDCTP3 Joint Undertaking, the African and European Research Partnership on Infectious Diseases, and the funders of this prestigious award.

The Executive Director highlighted Zambart's 35 years of impactful public health research, noting the organization's diverse portfolio of 23 research studies valued at USD 21.6 million. Zambart's expertise spans large-scale trials, epidemiological studies, randomized controlled trials, and implementation research.

Zambart has made significant contributions to TB/HIV policy and practice at national and global levels, influencing global health policies and demonstrating its ability to deliver impactful, multi-country randomized controlled trials.

Zambart's success is attributed to strategic partnerships and collaborations with renowned institutions and funders. The organization is also deeply invested in capacity development, collaborating with regional and international institutions to strengthen research capabilities.
Through partnerships, Zambart has hosted and mentored numerous students and research fellows, contributing to the next generation of public health researchers.

Dr. Shanaube concluded by expressing openness to exploring networks and collaborations, reaffirming Zambart's mission to contribute to global public health policy and practice through high-quality health research.

Announcing the winners, Dr Henning Gädeke, Chair of the EDCTP Association Board, praised the significant public health impact of Zambart over many years: “It’s a perfect example of how long-term cooperation of African and European partners can lead to results that really make a difference in people’s lives.”

19/06/2025

Ministry Of Health Lauds Zambart’s continued contribution towards elimination of TB.

Zambart, has taken a significant step forward in the fight against tuberculosis (TB) with the launch of The Lung Ultrasound for Tuberculosis Diagnosis: An Evaluation of Image-Acquisition Protocols and Probes (POCUS4TB). This groundbreaking initiative, funded by the National Institute for Health Research (NIHR) Global Health Research Groups, aims to improve early and accurate TB diagnosis using point-of-care lung ultrasound in high-burden settings.

The study is being implemented in collaboration with Kanyama Level One Hospital and is part of a global consortium working together to advance TB diagnostics. The POCUS4TB study seeks to evaluate the diagnostic accuracy of lung ultrasound, focusing on different acquisition protocols and probes.
of Health, Permanent Secretary, for Technical Services . Kennedy Lishimpi, commended Zambart for this on point-of-care lung ultrasound technology research, which will incorporate AI-assisted diagnostics, stating that it aligns with the Ministry ‘s broader strategy to leverage technological advancements for more efficient and accessible healthcare delivery.
“We applaud the efforts of Zambart and Kanyama Level One Hospital, and their partners involved in this initiative. Their collective expertise and dedication will ensure that research translates into impactful health interventions”
He added that strengthening collaboration across government agencies, health institutions, research bodies, and community stakeholders is essential for achieving sustainable health improvements.
He further stated that beyond the scope of the study, the Ministry remains committed to integrating innovative diagnostics within national TB programs, improving health infrastructure, and training healthcare personnel to effectively implement new technologies.
“This approach is aligned with our national TB elimination strategy, which emphasizes early detection, targeted treatment, and improved patient outcomes” he said.
Dr. Lishimpi, further reaffirmed the Ministry’s unwavering support for efforts that drive public health progress, enhance research-driven healthcare solutions, and, most importantly, improve the lives of all Zambians.
And Zambart Executive Director, Dr. Kwame Shanaube, said Tuberculosis remains one of the most pressing public health challenges, affecting millions worldwide, adding that the POCUS4TB study does not only have the potential to transform TB diagnostics in Zambia and beyond, but also marks a significant step towards reducing TB-related morbidity and mortality.
“Zambart's commitment to finding innovative solutions for TB diagnosis and treatment is demonstrated through its ongoing research studies, including:

- “Ubumi Bwandi” Integrated wellness screening and prevention in Zambia
- TB HEART (The burden of cardiac disease in TB infection in an HIV-prevalent setting)
- EPiTB (Addressing an unmet need: same-day diagnosis of extra-pulmonary TB in a high-burden setting)
- CommuniTB (GATES MRI) vaccine study
- XACT – 19 - Evaluating the impact of computer-assisted x-ray diagnosis and other triage tools
- Yaba Guy Che (For the men): Implementation and evaluation of a co-developed multi-disease intervention for men
- ZAMSA - Advancing epidemiological methods for surveillance of Mycobacterium Tuberculosis infection.

And Dr. Kondwelani Mateyo, CREATE PhD Fellow at Zambart and Consultant Pulmonologist at the University Teaching Hospital (UTH), said that the findings will help determine whether lung ultrasounds with AI integration can be incorporated into Zambia's health systems.
The study will enroll 2,700 adult participants, at Kanyama Level One Hospital which has been selected as the study site in Zambia, representing one of the country’s highest TB burden areas. The study is being conducted in collaboration with partners from Bolivia, Mozambique, Peru, and the UK.
London School of Hygiene & Tropical Medicine Ministry of Health Zambia Imagining